1.69 USD
▲+0.03+5.62%
盘后 1.56 -2.50%
2026-08-03
市值
$6.22M
市盈率
—
EPS
-17.16
股息率
—
52 周区间
1.25 – 17.64
成交量
147.61K
Beta
1.14
目标价
—
52W 低 1.2552W 高 17.64
价格走势
公司简介
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary...